Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23682,969,1.05 [0.93-1.18],0.4553459220676191
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,23597,189,1.11 [0.85-1.44],0.4409948932650868
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,25554,186,0.99 [0.75-1.29],0.91726814813528
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18051,746,1.07 [0.93-1.23],0.3485306730013628
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,25486,118,0.80 [0.57-1.14],0.2186510164793609
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,24450,83,1.36 [0.93-1.97],0.1085919088537225
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",26906,117,0.81 [0.57-1.15],0.2310660625066126
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,26900,78,0.71 [0.46-1.10],0.1266507522480206
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,23843,63,1.16 [0.74-1.82],0.5117287552365544
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26252,116,1.22 [0.89-1.69],0.219320875485286
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26206,70,1.36 [0.91-2.05],0.1335633359226433
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,26986,74,1.16 [0.77-1.74],0.4874544663320738
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other viral diseases,26949,99,0.96 [0.66-1.38],0.8091323197230489
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",26944,94,0.97 [0.67-1.42],0.8878758977476687
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Mycoses,26611,61,0.98 [0.62-1.57],0.9471486497742304
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",25820,429,1.12 [0.95-1.34],0.183016280573289
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,25521,130,1.32 [0.98-1.77],0.068572121533454
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,25688,297,1.09 [0.88-1.34],0.4436018385318563
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22094,51,0.91 [0.54-1.53],0.7185976521210556
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22107,64,nan [nan-nan],
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22297,254,nan [nan-nan],
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",22305,262,nan [nan-nan],
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",22698,655,1.01 [0.88-1.17],0.8572091616303108
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22093,50,1.14 [0.69-1.88],0.6178072826550819
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,24204,1004,1.16 [1.03-1.30],0.0112811549396934
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",25932,286,1.01 [0.82-1.26],0.9113892584780856
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,26648,106,0.91 [0.63-1.30],0.5870484945868715
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27079,89,0.92 [0.62-1.36],0.683488123368918
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Rectum,26860,56,1.60 [1.05-2.44],0.0278381717782063
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27076,66,1.08 [0.69-1.67],0.7439550960094108
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Stomach,27122,52,1.19 [0.74-1.92],0.4791671555027769
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm,26899,270,0.97 [0.77-1.21],0.759559638104252
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27069,106,1.19 [0.85-1.67],0.3137941550626025
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27069,105,0.84 [0.58-1.21],0.3512055666558465
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27004,68,0.88 [0.56-1.38],0.5793667948994419
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma, any site",27005,67,0.94 [0.60-1.48],0.7996045099182622
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi,26912,257,1.05 [0.84-1.32],0.6626801096187571
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27080,117,1.16 [0.84-1.60],0.371411661274411
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Other benign neoplasms of skin,26976,226,0.90 [0.70-1.15],0.3991426283521008
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of breast,27059,138,0.83 [0.60-1.15],0.2596666596009328
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Leiomyoma of uterus,26565,980,0.95 [0.84-1.07],0.3806598159373718
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,25736,262,1.17 [0.94-1.46],0.1526016335393951
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,25483,443,1.20 [1.01-1.42],0.0354244212056137
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,25483,443,1.20 [1.01-1.42],0.0354244212056137
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23955,408,1.24 [1.04-1.47],0.0173464318198865
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,26570,98,0.78 [0.53-1.14],0.2028672318553949
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,26778,106,1.47 [1.07-2.03],0.018830301668432
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22465,903,1.18 [1.05-1.34],0.0075109118453051
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,24831,883,1.08 [0.95-1.22],0.2312823194469616
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25308,120,1.03 [0.74-1.43],0.8628313679270669
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26141,58,1.20 [0.75-1.90],0.4482308102936816
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25295,107,1.11 [0.79-1.57],0.5413945888428515
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,25593,405,1.19 [0.99-1.42],0.0677934549640637
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,25584,396,1.21 [1.01-1.45],0.0437595373487046
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25066,190,0.97 [0.73-1.31],0.8575977161665607
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25071,189,0.99 [0.74-1.33],0.9306662359987734
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22274,712,1.15 [1.00-1.32],0.0509042053506933
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",21644,82,1.26 [0.86-1.86],0.2384618549146271
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22222,660,1.14 [0.99-1.32],0.0783801812476796
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,21611,49,1.63 [1.03-2.57],0.0363692771133409
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21633,71,1.43 [0.97-2.13],0.073104523203866
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Any mental disorder,22864,614,1.09 [0.94-1.26],0.266737312574864
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22367,117,1.01 [0.71-1.43],0.9545401419026862
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",26885,78,0.68 [0.44-1.06],0.091052058351878
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",26924,46,0.50 [0.27-0.92],0.0248102646654551
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,25692,38,0.72 [0.38-1.35],0.30313838348926
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27072,38,0.68 [0.36-1.28],0.2354727613310198
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",22288,38,0.73 [0.39-1.37],0.3300005322297702
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Alcohol dependence,25678,24,0.42 [0.18-0.98],0.0442025322139575
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Smoking dependency,25575,35,1.62 [0.90-2.90],0.1070680140570808
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22293,43,0.88 [0.49-1.56],0.6537302293124261
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22627,377,1.07 [0.88-1.29],0.5000733924231524
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Depression,25150,337,1.06 [0.87-1.29],0.5647012918589462
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Depression or dysthymia,22411,295,1.17 [0.95-1.44],0.148380864548809
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",22396,146,1.11 [0.82-1.49],0.4949538542915345
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Other anxiety disorders,25238,76,0.96 [0.63-1.46],0.8441102826101801
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Neurological diseases,23369,1606,1.14 [1.04-1.25],0.0046718826838531
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21355,176,1.09 [0.83-1.42],0.5539113593677787
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,26927,146,1.13 [0.84-1.51],0.4155673191367732
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,25800,419,1.11 [0.93-1.32],0.2581281504295032
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Epilepsy,25518,137,1.29 [0.96-1.73],0.0894553224889705
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Migraine,25506,125,1.14 [0.83-1.56],0.4313923106089588
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",26686,117,1.12 [0.81-1.56],0.4820833275608954
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Transient ischemic attack,26429,58,1.36 [0.88-2.12],0.1688804904287267
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other sleep disorders,25477,96,0.87 [0.59-1.28],0.4761914346497679
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Sleep apnoea,26708,67,0.89 [0.56-1.40],0.6090568138841128
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",25762,850,1.13 [1.00-1.28],0.0513556702880186
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25031,119,1.27 [0.93-1.74],0.1387155201824163
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,25453,541,1.09 [0.93-1.27],0.292865437053406
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,26865,75,0.93 [0.61-1.43],0.7373022569473293
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hemiplegia,26846,56,0.87 [0.53-1.45],0.6006113392528418
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other neurological diseases,26639,119,1.02 [0.73-1.43],0.8966856069658006
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26393,421,1.03 [0.87-1.24],0.708696071150829
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26218,246,1.08 [0.86-1.36],0.5086206901344101
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26044,72,0.78 [0.50-1.23],0.2845568025572249
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26102,130,1.13 [0.83-1.54],0.4409832483788266
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26076,104,1.47 [1.07-2.02],0.0182823122798646
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23054,177,1.11 [0.85-1.45],0.4549383453366795
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23281,404,1.08 [0.90-1.29],0.4360921781477119
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26083,179,1.18 [0.91-1.54],0.2042307249120932
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,26854,34,1.51 [0.88-2.62],0.1365166529494357
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1741,34,1.37 [0.75-2.50],0.3040474749744561
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25147,34,1.54 [0.90-2.63],0.1191768469037563
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,26425,90,1.10 [0.76-1.61],0.6028697481186338
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26387,52,1.29 [0.81-2.07],0.2786208929387478
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",26296,95,1.29 [0.91-1.83],0.1493758110188948
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,26553,103,0.73 [0.50-1.06],0.1014485239274383
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27000,128,1.30 [0.96-1.75],0.0905729841338841
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,26326,106,1.22 [0.87-1.71],0.2461771277172756
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19965,2763,1.14 [1.05-1.23],0.0017456112271091
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,26544,73,0.85 [0.55-1.32],0.466785503381966
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20957,2038,1.14 [1.04-1.25],0.0035425653483571
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertension,20978,2059,1.14 [1.04-1.25],0.0036229450320623
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18967,48,1.56 [0.96-2.51],0.0713846412236212
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",25465,721,1.13 [0.98-1.29],0.0845056658361937
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Angina pectoris,25243,499,1.11 [0.94-1.30],0.2294553372598479
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26461,146,0.95 [0.70-1.29],0.7278277229172085
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,26539,224,0.97 [0.76-1.24],0.7905907181354803
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27054,26,1.05 [0.51-2.13],0.9011797634676358
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",24838,94,1.04 [0.72-1.51],0.8403667978376357
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25212,478,1.15 [0.97-1.35],0.1090343765044625
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26345,97,1.21 [0.85-1.72],0.2946135394257151
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Venous thromboembolism,26448,215,1.05 [0.82-1.35],0.6724150293655777
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26342,94,0.85 [0.58-1.25],0.4090213580180957
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26342,94,0.85 [0.58-1.25],0.4090213580180957
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19011,92,0.89 [0.60-1.32],0.5513349845347599
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiomyopathy,23562,39,1.71 [1.06-2.77],0.0292201321401171
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Conduction disorders,23604,81,1.12 [0.75-1.66],0.5811190991898567
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16270,99,1.05 [0.73-1.51],0.786630460938575
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16445,274,0.99 [0.79-1.24],0.9317052751800214
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arrhythmias,23574,51,1.28 [0.79-2.06],0.3179714293217884
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,23580,57,0.87 [0.53-1.42],0.5778032290704331
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Heart failure, strict",26291,101,1.33 [0.95-1.87],0.0959640974973158
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26342,127,1.04 [0.75-1.43],0.8237839316024214
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26382,95,0.98 [0.67-1.43],0.9113644602240576
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",26454,83,1.04 [0.70-1.55],0.8323181662675506
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26165,69,1.19 [0.78-1.82],0.4108865637854884
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26206,110,1.02 [0.72-1.44],0.90702729312037
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),25515,131,1.02 [0.74-1.40],0.8987665528673636
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,DVT of lower extremities,25490,106,1.06 [0.75-1.51],0.73417781553229
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",26907,103,1.04 [0.73-1.49],0.8291510122882881
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Varicose veins,25988,604,0.87 [0.74-1.01],0.0670559414289698
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypotension,25995,92,1.16 [0.81-1.68],0.4167937631878551
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22039,2062,1.12 [1.03-1.21],0.0105857798245079
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,26912,125,1.12 [0.81-1.54],0.4828586701524969
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Influenza and pneumonia,25505,195,1.04 [0.80-1.35],0.7553376021160215
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",25487,177,1.03 [0.79-1.36],0.8068772643686841
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26231,223,1.04 [0.81-1.32],0.7752687219106564
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26223,215,1.05 [0.82-1.34],0.7233752002102191
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26358,557,1.03 [0.88-1.20],0.7414962373187379
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic sinusitis,25914,113,1.17 [0.84-1.62],0.3601605315555723
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Nasal polyp,25881,80,1.20 [0.82-1.77],0.3529305175972761
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26151,350,1.00 [0.82-1.21],0.9609448951006356
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Deviated nasal septum,25936,135,0.97 [0.71-1.33],0.8461277187302841
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13071,65,0.80 [0.50-1.29],0.352778180529654
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,24223,1139,1.13 [1.01-1.26],0.0323388560475901
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Early onset COPD,26070,152,1.23 [0.92-1.64],0.1667135897795717
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26090,172,1.13 [0.85-1.48],0.4036764724341942
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26090,172,1.13 [0.85-1.48],0.4036764724341942
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25116,982,1.12 [0.99-1.25],0.0649352921520697
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Asthma,20144,982,1.15 [1.02-1.29],0.0224563029432874
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19958,982,1.15 [1.02-1.29],0.0219264231609556
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20130,968,1.13 [1.00-1.27],0.0427250961060305
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,26802,81,1.04 [0.69-1.55],0.8581879461228231
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Interstitial lung disease,25369,60,0.98 [0.61-1.57],0.9240618433484752
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",26875,60,0.98 [0.61-1.58],0.947714483444556
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25362,53,0.90 [0.54-1.50],0.6885909487217128
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural effusion,25305,86,1.20 [0.82-1.75],0.3483825170265288
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of pleura,25408,189,1.08 [0.83-1.41],0.5494267854061383
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,25970,89,0.95 [0.64-1.40],0.7936757505659933
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18770,5925,1.07 [1.01-1.14],0.0202883153814701
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",26566,462,1.09 [0.92-1.29],0.3245103011763622
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27079,105,1.03 [0.72-1.47],0.862940839682336
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impacted teeth,27084,95,1.14 [0.79-1.64],0.4820354615099448
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Dental caries,26206,102,0.98 [0.68-1.41],0.8991589725765814
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26220,116,1.19 [0.86-1.65],0.2814761449423715
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27071,116,1.05 [0.75-1.48],0.760367978707409
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26214,110,1.11 [0.79-1.56],0.5494133773109569
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,25921,79,1.26 [0.86-1.86],0.2376991217640471
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,26985,49,1.14 [0.69-1.89],0.615204162000935
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20503,222,0.80 [0.62-1.03],0.082304050947643
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22565,2284,1.03 [0.95-1.11],0.5230847256426876
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophagitis,20559,278,1.26 [1.03-1.55],0.0281726303977445
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21010,729,1.02 [0.89-1.17],0.7335162603818677
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20361,80,1.28 [0.87-1.88],0.2035723520398445
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20414,133,1.26 [0.94-1.70],0.1195995713451093
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20322,41,0.67 [0.36-1.24],0.2000011774783242
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastric ulcer,20427,146,0.69 [0.50-0.95],0.0223286368199977
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Duodenal ulcer,20358,77,1.16 [0.77-1.73],0.4806141551159959
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27032,55,1.06 [0.65-1.72],0.8233350652834016
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic gastritis,20411,130,0.97 [0.71-1.35],0.8746561902220608
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21106,825,1.01 [0.89-1.15],0.905368131189172
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of appendix,26950,145,1.09 [0.81-1.47],0.5640808778401258
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Functional dyspepsia,20857,576,0.96 [0.82-1.12],0.5621781519467841
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20459,178,0.98 [0.75-1.29],0.9127656384784334
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,26990,140,1.05 [0.78-1.43],0.7421516662015195
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute appendicitis,26922,117,1.02 [0.73-1.43],0.8883912309022058
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Hernia,24262,1181,1.08 [0.97-1.20],0.1753555287234249
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Inguinal hernia,23147,66,1.20 [0.78-1.84],0.4034607687986138
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Umbilical hernia,23152,71,1.45 [0.98-2.16],0.0627442425760286
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ventral hernia,23190,109,1.13 [0.81-1.59],0.4768979797289565
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24021,940,1.06 [0.93-1.19],0.3849276334923892
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26043,903,1.07 [0.95-1.21],0.2495159090346694
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestines,21455,2157,1.05 [0.96-1.14],0.2662890439075378
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",26771,60,0.75 [0.46-1.23],0.2583064211045516
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27045,88,0.73 [0.49-1.10],0.1361907158345833
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn disease,25228,88,0.74 [0.49-1.11],0.148028067765098
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25204,64,0.67 [0.41-1.09],0.1092472778224829
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",26975,134,0.99 [0.72-1.36],0.9556549067052436
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcerative colitis,25274,134,1.00 [0.73-1.37],0.9865948949750976
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25260,120,0.93 [0.67-1.31],0.6906508381288976
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,25907,767,1.13 [0.99-1.29],0.0674859242401378
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,25896,756,1.12 [0.99-1.28],0.082010644513749
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19401,103,1.25 [0.89-1.75],0.1955235504168205
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal stricture,26650,103,1.25 [0.89-1.75],0.1965391578903886
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19363,65,1.08 [0.69-1.67],0.742630496181627
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19959,661,0.98 [0.85-1.14],0.834603557234057
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19537,239,1.02 [0.81-1.29],0.8783593226228904
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19685,387,1.18 [0.99-1.41],0.0704536971135063
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Constipation,25425,344,1.18 [0.97-1.42],0.0917459204571669
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of peritoneum,26611,126,1.05 [0.76-1.44],0.7748038390920094
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19421,123,1.16 [0.84-1.59],0.3644644838142542
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19340,42,0.75 [0.41-1.35],0.3358536931088818
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20184,886,1.06 [0.93-1.20],0.3905549290388067
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestine,19525,227,0.86 [0.67-1.10],0.2355997438584373
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,26593,108,1.01 [0.71-1.43],0.9595539625910524
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of liver,26335,104,0.83 [0.57-1.20],0.3145656578840134
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of liver,26286,55,1.00 [0.62-1.63],0.9940066962569796
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",25559,863,1.09 [0.96-1.24],0.1710641559713847
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholelithiasis,25421,725,1.09 [0.95-1.24],0.2347564742256248
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholecystitis,24825,129,1.48 [1.11-1.97],0.0081028558916637
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,24763,67,1.19 [0.78-1.83],0.4239422868822481
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis,24755,59,1.11 [0.70-1.77],0.6556850137919903
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),26961,59,1.09 [0.68-1.74],0.7130611187364554
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of the digestive system,25756,298,1.20 [0.98-1.47],0.0828189701076271
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal malabsorption,25558,100,nan [nan-nan],
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Coeliac disease,25543,85,nan [nan-nan],
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",25496,38,1.26 [0.72-2.20],0.4221184473351784
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,25624,166,1.12 [0.85-1.48],0.4071540620254678
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,GI-bleeding,25614,156,1.09 [0.81-1.45],0.5769689954001104
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,23997,1595,0.99 [0.90-1.09],0.8230383475266708
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,26660,112,0.96 [0.68-1.36],0.8052745469248861
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,26667,454,1.04 [0.87-1.23],0.6744032792963608
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,25559,691,1.05 [0.91-1.21],0.4843365665272987
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26305,314,0.96 [0.78-1.18],0.7122450875898181
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26060,69,0.97 [0.62-1.51],0.8796245743786167
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26189,198,0.96 [0.74-1.24],0.7426578488891744
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,26834,88,0.90 [0.61-1.34],0.5993077302222778
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,26809,63,0.85 [0.53-1.37],0.5031667501007575
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,26795,49,0.85 [0.50-1.46],0.5637299495051241
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,26845,52,0.82 [0.49-1.39],0.4607630801025546
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,26842,49,0.86 [0.50-1.46],0.5751125859673292
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26271,58,1.30 [0.83-2.03],0.2530318939349035
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,26567,354,1.00 [0.82-1.21],0.9916826343611396
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,24971,103,0.76 [0.52-1.11],0.1500267211118382
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25021,153,0.87 [0.65-1.18],0.3817366608965469
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,24979,111,0.92 [0.65-1.31],0.6430659542519382
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25122,254,1.13 [0.90-1.41],0.2824374025292049
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25096,228,1.10 [0.87-1.39],0.4276947494832925
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19102,4319,1.07 [1.00-1.14],0.0495700124784713
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20807,2477,1.05 [0.97-1.13],0.2723983378792258
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,24343,1318,1.14 [1.03-1.26],0.0104591729199314
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18541,211,1.18 [0.92-1.50],0.1902361946288696
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18840,510,1.04 [0.89-1.23],0.5990539161370968
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",26535,202,1.20 [0.94-1.54],0.1417770522666693
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,26551,184,1.25 [0.97-1.61],0.0904516305557671
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19538,1208,1.10 [0.98-1.22],0.1068672800078859
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22195,1208,1.09 [0.98-1.21],0.1292840436412724
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18341,11,0.27 [0.08-0.96],0.043056952807388
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",26917,11,0.25 [0.07-0.93],0.0387296768214068
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18602,272,1.06 [0.85-1.32],0.5900615776950134
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18415,85,0.96 [0.64-1.43],0.8402257291582456
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18636,306,1.18 [0.96-1.44],0.1142606718843169
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",26919,154,1.35 [1.03-1.77],0.0310881427998747
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18804,474,1.06 [0.89-1.26],0.5116632539662718
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18809,479,1.04 [0.88-1.24],0.6180298829144719
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19712,1382,1.03 [0.93-1.14],0.5751694745582486
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18434,104,1.10 [0.78-1.55],0.6013068462571619
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18745,415,0.99 [0.83-1.19],0.9502943593835568
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18410,80,1.05 [0.70-1.56],0.8273030559368293
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18433,103,1.22 [0.87-1.71],0.2509195981025093
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18688,358,0.99 [0.81-1.20],0.9088790848829268
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18633,303,1.05 [0.85-1.29],0.6550264964682567
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20216,296,1.12 [0.91-1.38],0.3010045182807855
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26321,216,1.00 [0.78-1.29],0.9922044595309404
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26197,92,1.35 [0.95-1.92],0.0947653960496949
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23200,82,1.11 [0.75-1.64],0.6181824911942069
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,23420,302,1.02 [0.82-1.26],0.8758145925551131
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24132,1014,0.96 [0.85-1.08],0.478846105378951
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,23331,213,1.02 [0.79-1.31],0.8816844740909638
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23194,76,1.09 [0.72-1.64],0.6824942064585057
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",23928,810,0.96 [0.84-1.09],0.506366474003733
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23169,51,1.25 [0.77-2.03],0.3589873978901302
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23355,237,1.06 [0.84-1.34],0.6375674435690387
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23217,99,1.11 [0.77-1.58],0.5770407821986618
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23209,91,0.83 [0.56-1.24],0.3704330837060977
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23279,161,0.89 [0.66-1.20],0.4443744598304007
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23193,75,1.12 [0.74-1.69],0.5890676345611652
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23470,352,1.06 [0.88-1.29],0.541197279127924
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23407,382,1.19 [0.99-1.42],0.0610271064861765
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23096,71,1.02 [0.67-1.57],0.9232496839583872
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23134,109,0.94 [0.66-1.33],0.720100985432109
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23168,143,1.45 [1.10-1.92],0.0081273393090377
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23061,36,1.28 [0.72-2.27],0.4006739702452594
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23080,55,1.34 [0.86-2.11],0.1986091689988557
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23066,41,1.03 [0.59-1.80],0.9155582760737314
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23299,274,1.09 [0.88-1.36],0.4206521708021742
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23084,59,0.77 [0.47-1.27],0.3039065779211417
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23094,69,1.15 [0.75-1.76],0.5258538195024185
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23162,137,1.11 [0.82-1.51],0.4930726425096976
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23103,78,0.75 [0.48-1.15],0.1859621817402535
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",23560,535,1.10 [0.94-1.29],0.2160422226997361
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23216,191,1.07 [0.83-1.39],0.5859207021750832
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23311,286,1.08 [0.87-1.34],0.489811976334956
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,24407,234,1.01 [0.80-1.28],0.9277038953912092
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,24652,479,0.97 [0.81-1.14],0.6864678054264223
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24212,39,1.10 [0.63-1.95],0.7323410335946797
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24239,66,0.85 [0.54-1.35],0.4996974049964388
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24289,116,0.82 [0.58-1.17],0.2691226801967592
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22119,6018,0.97 [0.92-1.02],0.2568496388003024
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24696,195,1.38 [1.08-1.76],0.0092187670731114
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,24544,43,1.99 [1.29-3.08],0.0018461253451265
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24865,35,2.05 [1.25-3.38],0.0044985870174619
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,24876,46,1.32 [0.79-2.20],0.2893155413346632
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,24870,40,1.59 [0.96-2.64],0.0691012850725278
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urolithiasis,26873,130,0.91 [0.66-1.26],0.5680355190565431
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,26751,64,1.21 [0.78-1.87],0.3907409554807044
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,26844,101,1.06 [0.74-1.52],0.7368320357417868
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,26776,33,0.61 [0.30-1.21],0.1551830941505939
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,24923,1233,1.02 [0.92-1.14],0.6811295927043386
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cystitis,23821,131,1.05 [0.77-1.44],0.7609267405918035
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,23779,89,1.01 [0.69-1.48],0.96364634114521
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,23855,165,1.11 [0.84-1.46],0.4706545666516187
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urethral stricture,23776,86,1.01 [0.68-1.50],0.9600943446467264
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,24661,971,1.04 [0.92-1.17],0.5265994773757513
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26800,473,0.95 [0.81-1.13],0.5903770078599306
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26474,147,0.94 [0.70-1.28],0.6967144541196799
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,26495,168,0.97 [0.73-1.29],0.8311999456856134
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26438,111,0.97 [0.69-1.37],0.8725658422630485
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26746,542,1.00 [0.86-1.17],0.9685602718171384
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26334,130,0.81 [0.58-1.12],0.2014988731704564
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26445,241,1.05 [0.83-1.33],0.6770353562328093
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,24702,4510,0.95 [0.90-1.01],0.1357069105799347
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Endometriosis,20551,359,1.12 [0.92-1.36],0.250900848813459
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20288,96,1.21 [0.84-1.74],0.3021433617922117
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20356,164,1.15 [0.87-1.52],0.3112314786327681
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,20970,778,1.04 [0.91-1.18],0.5867505259919141
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20600,408,0.96 [0.80-1.16],0.6816475028761466
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21128,936,0.89 [0.78-1.00],0.056012769830082
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20502,310,0.80 [0.65-1.00],0.0491277359778559
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20628,436,0.96 [0.80-1.14],0.6163500826362454
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20287,95,1.02 [0.70-1.49],0.9139357303343512
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20376,184,1.07 [0.82-1.41],0.600977561326878
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27076,260,1.13 [0.90-1.41],0.289601165226439
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27086,246,1.15 [0.92-1.45],0.2157634021350086
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27111,137,1.27 [0.94-1.71],0.1186121674051882
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27102,151,1.24 [0.93-1.65],0.138410771764966
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20336,144,0.96 [0.71-1.31],0.8008853845287903
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20305,113,0.77 [0.53-1.10],0.1535102696705495
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20332,140,1.17 [0.87-1.58],0.3034848815084736
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Irregular menses,27007,463,1.14 [0.97-1.34],0.1235081815681027
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21511,1319,1.01 [0.91-1.12],0.8155044416916658
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21050,858,0.95 [0.84-1.08],0.4588880709408497
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27092,194,1.02 [0.79-1.32],0.8772716559661354
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20652,460,0.83 [0.69-0.99],0.0396034662256191
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20519,327,0.93 [0.75-1.14],0.4752058106179806
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21074,882,0.90 [0.79-1.02],0.0922792612243577
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Female infertility,20307,115,1.10 [0.78-1.55],0.6008954717549503
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20300,108,1.08 [0.75-1.54],0.6791415310519786
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27107,863,0.85 [0.74-0.98],0.0267549874232982
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27112,1171,0.85 [0.75-0.96],0.0097506129904432
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27108,463,1.02 [0.85-1.22],0.8588780835547889
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,26776,131,0.91 [0.65-1.27],0.5742263136564725
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,26834,189,0.86 [0.65-1.14],0.2968528681491452
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,26800,155,1.25 [0.94-1.68],0.1276111315105502
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27127,165,0.66 [0.48-0.90],0.0087533627033278
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27129,162,0.65 [0.47-0.89],0.0065242503043292
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27124,406,0.76 [0.62-0.93],0.0082913656627812
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,26837,119,0.49 [0.33-0.72],0.0002349266551741
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,26945,227,0.82 [0.63-1.06],0.1279605199495463
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26389,145,0.95 [0.69-1.31],0.7610727617301687
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,26440,196,0.78 [0.59-1.04],0.0932324943869245
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,26492,248,0.84 [0.65-1.08],0.1725866787737019
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26388,144,0.89 [0.64-1.23],0.4656226895309893
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26379,135,0.91 [0.65-1.27],0.5850959272599465
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26393,149,0.67 [0.48-0.93],0.0177804745342226
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26168,227,0.82 [0.63-1.07],0.148497844613317
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26364,423,0.78 [0.64-0.95],0.0151169654638935
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,26591,650,0.83 [0.71-0.98],0.0296468162261088
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27129,165,1.01 [0.75-1.36],0.9466753394922194
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,25700,126,0.89 [0.63-1.26],0.5187620914206674
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26040,99,0.92 [0.63-1.36],0.6857103811721861
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27137,332,0.76 [0.61-0.95],0.0150447594331341
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27056,251,0.67 [0.52-0.87],0.0023844864651885
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27124,247,0.97 [0.76-1.24],0.7881527206947292
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27115,238,0.99 [0.77-1.27],0.9353221985234452
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",26836,43,1.09 [0.63-1.88],0.7586816781829782
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24256,633,0.92 [0.79-1.07],0.2715249158644948
